Abstract
El vitíligo es una enfermedad dermatológica frecuente que afecta a alrededor del 1% de la población mundial. Aunque no es considerada una enfermedad con riesgo de morbimortalidad elevado, se ha evidenciado que puede asociarse con manifestaciones psicopatológicas diversas que pudieran ser una consecuencia de la misma. En el presente artículo se lleva a cabo una revisión de las evidencias actuales sobre la relación existente entre el vitíligo, los parámetros definitorios de calidad de vida, la presencia de trastornos afectivos y el posible vínculo con el aumento del riesgo de ideación suicida. Es claro que la identificación de los factores de riesgo es de suma utilidad para que los profesionales de la dermatología puedan detectar pacientes que deban ser manejados psicológicamente de manera concomitante.References
Ahmed, I., Ahmed, S. y Nasreen, S. (2013). Frequency and pattern of psychiatric disorders in patients with vitiligo. Journal of Ayub Medical College Abbottabad, 9(3), 19-21.
Al-Harbi, M. (2013). Prevalence of depression in vitiligo patients. SkinMedica, 11(6), 327-330.
Alkhateeb, A., Fain, P.R., Thody, A., Bennett, D.C. y Spritz, R.A. (2003). Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Research, 16, 208-214.
Amer, A.A. y Gao, X.H. (2016): Quality of life in patients with vitiligo: An analysis of the dermatology life quality index outcome over the past two decades. International Journal of Dermatology, 55(6), 608-614.
Bhandarkar, S.S. y Kundu, R.V. (2012). Quality-of-life issues in vitiligo. Dermatologic Clinics, 30(2), 255-268.
Bilgiç, Ö., Bilgiç, A., Akiş, H.K., Eskioğlu, F. y Kiliç, E.Z. (2011). Depression, anxiety and health‐related quality of life in children and adolescents with vitíligo. Clinical and Experimental Dermatology, 36(4), 360-365.
Chan, M.F., Chua, T.L., Goh, B.K., Aw, C.W., Thng, T.G. y Lee, S.M. (2012). Investigating factors associated with depression of vitiligo patients in Singapore. Journal of Clinical Nursing, 21(11-12), 1614-1621.
Dolatshahi, M., Ghazi, P., Feizy, V. y Hemami, M.R. (2008). Life quality assessment among patients with vitiligo: Comparison of married and single patients in Iran. Indian Journal of Dermatology, Venereology and Leprology, 74(6), 700.
Eguiluz, L. (1995). Estudio exploratorio de la ideación suicida entre los jóvenes. Memorias del XV Coloquio de Investigación (pp. 121-130). México: UNAM.
Elbuluk, N. y Ezzedine, K. (2017). Quality of life, burden of disease, co-morbidities, and systemic effects in vitiligo patients. Dermatologic Clinics, 35(2), 117-128.
Hedayat, K., Karbakhsh, M., Ghiasi, M., Goodarzi, A., Fakour, Y., Akbari, Z., Ghayoumi, A. y Ghandi, N. (2016). Quality of life in patients with vitiligo: a cross-sectional study based on Vitiligo Quality of Life index (VitiQoL). Health and Quality of Life Outcomes, 14, 86.
Jiménez, T. y González-Forteza, C. (2003). Veinticinco años de investigación sobre suicidio en la Dirección de Investigaciones Epidemiológicas y Psicosociales del Instituto Nacional de Psiquiatría “Ramón de la Fuente”. Salud Mental, 26(6), 35-51.
Karelson, M., Silm, H. y Kingo, K. (2013). Quality of life and emotional state in vitiligo in an Estonian sample: comparison with psoriasis and healthy controls. Acta Dermato-Venereologica, 93(4), 446-450.
Kostopoulou, P., Jouary, T., Quintard, B., Ezzedine, K., Marques, S., Boutchnei, S. y Taieb, A. (2009). Objective vs. subjective factors in the psychological impact of vitiligo: The experience from a French referral centre. British Journal of Dermatology, 161(1), 128-133.
Kota, R.S., Vora, R.V., Varma, J.R., Kota, S.K., Patel, T.M. y Ganjiwale, J. (2019). Study on assessment of quality of life and depression in patients of vitiligo. Indian Dermatology Online Journal, 10(2), 153-157.
Krishna, G.S., Ramam, M., Mehta, M., Sreenivas, V., Sharma, V.K. y Khandpur, S. (2013). Vitiligo impact scale: an instrument to assess the psychosocial burden of vitiligo. Indian Journal of Dermatology, Venereology and Leprology, 79(2), 205-210.
Krüger, C.L. y Schallreuter, K.U. (2013). Cumulative life course impairment in vitiligo. Current Problems in Dermatology, 44, 102-117.
Krüger, C.L. y Schallreuter, K.U. (2015). Stigmatisation, avoidance behaviour and difficulties in coping are common among adult patients with vitiligo. Acta Dermato-Venereologica, 95(5), 553-558.
Lai, Y.C., Yew, Y.W., Kennedy, C. y Schwartz, R.A. (2017). Vitiligo and depression: a systematic review and meta-analysis of observational studies. British Journal of Dermatology, 177(3), 708-718.
Mechri, A., Amri, M., Douarika, A.A., Hichem, B.H., Zouari, B. y Zili, J. (2006). Psychiatric morbidity and quality of life in Vitiligo: a case controlled study. La Tunisie Medicale, 84(10), 632-635.
Morales S., M.A., Vargas S., M., Peralta P., M.L., Olguín G., M.G. y Jurado S., C.F. (2017). Impact of vitiligo on quality of life. Actas Dermo-Sifiliográficas, 108(7), 637-642.
Nguyen, C., Beroukhim, K., Danesh, M., Babikian, A., Koo, J. y Leon, A. (2016). The psychosocial impact of acne, vitiligo, and psoriasis: a review. Clinical, Cosmetic and Investigational Dermatology, 9, 383-392.
Osinubi, O., Grainge, M.J., Hong, L., Ahmed, A., Batchelor, J.M., Grindlay, D., Thompson, A.R. y Ratib, S. (2018). The prevalence of psychological comorbidity in people with vitiligo: a systematic review and meta-analysis. British Journal of Dermatology, 178(4), 863-878.
Pahwa, P., Mehta, M., Khaitan, B.K., Sharma, V.K. y Ramam, M. (2013). The psychosocial impact of vitiligo in Indian patients. Indian Journal of Dermatology, Venereology and Leprology, 79(5), 679-685.
Patel, K.R., Singam, V., Rastogi, S., Lee, H.H., Silverberg, N.B. y Silverberg, J.I. (2019). Association of vitiligo with hospitalization for mental health disorders in U.S. adults. European Academy of Dermatology and Venereology, 33(1), 191-197.
Pérez, S. (1999). El suicidio, comportamiento y prevención. Revista Cubana de Medicina General, 15(2), 196-217.
Prćić, S., Durović, D., Duran, V., Vuković, D. y Gajinov, Z. (2006). Some psychological characteristics of children and adolescents with vitíligo ˗our results. Medicinski pregled, 59(5-6), 265-269.
Ramakrishna, P. y Rajni, T. (2014). Psychiatric morbidity and quality of life in vitiligo patients. Indian Journal of Psychological Medicine, 36(3), 302-303.
Sampogna, F., Raskovic, D., Guerra, L., Pedicelli, C., Tabolli, S., Leoni, L., Alessandroni, L. y Abeni, D. (2008). Identification of categories at risk for high quality of life impairment in patients with vitiligo. British Journal of Dermatology, 159(2), 351-359.
Sangma, L.N., Nath, J. y Bhagabati, D. (2015). Quality of life and psychological morbidity in vitiligo patients: a study in a teaching hospital from north-East India. Indian Journal of Dermatology, 60(2), 142-146.
Sarkar, S., Sarkar, T., Sarkar, A. y Das, S. (2018). Vitiligo and psychiatric morbidity: a profile from a vitiligo clinic of a rural-based tertiary care center of Eastern India. Indian Journal of Dermatology, 63(4), 281-284.
Sawant, N., Vanjari, N. y Khopkar, U. (2019). Gender differences in depression, coping, stigma, and quality of life in patients of vitiligo. Dermatology Research and Practice, Article ID 6879412.
Tarlé, R.G., Nascimento, L.M., Mira, M.T. y Silva de C., C.C. (2014). Vitiligo, Part 1. Brazilian Annals of Dermatology, 89(3), 461-470.
Vallerand, I.A., Lewinson, R.T., Parsons, L.M., Hardin, J., Haber, R.M., Lowerison, M.W., Barnabe, C. y Patten, S.B. (2019). Vitiligo and major depressive disorder: A bidirectional population-based cohort study. Journal of the American Academy of Dermatology, 80(5), 1371-1379.
Wang, G., Qiu, D., Yang, H. y Liu, W. (2018). The prevalence and odds of depression in patients with vitiligo: a meta-analysis. Journal of the European Academy of Dermatology and Venereology, 32(8), 1343-1351.